Literature DB >> 12067998

Genotoxic exposure is associated with alterations in glucose uptake and metabolism.

Rixin Zhou1, Matthew G Vander Heiden, Charles M Rudin.   

Abstract

Recent observations suggest that growth factor withdrawal can promote cell death in part through modulation of basic cellular bioenergetic pathways, including inhibition of glucose uptake and glycolytic metabolism. Whether DNA damage-initiated cell death pathways also involve bioenergetic deregulation has not been studied previously. Subtractive suppressive hybridization was used to identify changes in gene expression in murine cells after exposure to genotoxic stimuli, including cisplatin, etoposide, and gamma-radiation. Among the genes identified in this screen were several that regulate glycolytic metabolism. Enzymes that catalyze key regulatory steps of glycolysis, including hexokinase, phosphofructokinase, and pyruvate kinase, appeared to be coordinately down-regulated by genotoxic exposure. Northern blotting confirmed that these changes in gene expression occur within 4 h of exposure to several DNA-damaging agents. Genotoxic exposure was found to similarly inhibit expression of both glut-1 and glut-3, genes that encode critical regulators of glucose uptake. Direct measurement of glycolytic rate and of oxygen consumption confirmed that genotoxic exposure resulted in suppression of both anaerobic and aerobic metabolism. Many of these metabolic changes mimic those observed after growth factor withdrawal. Together, these observations suggest that multiple apoptotic triggers, including growth factor withdrawal and genotoxic exposure, suppress cellular bioenergetic pathways. Mitochondrial responses to the resulting rapid decrease in metabolic substrates may play an important role in initiation of apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067998

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells.

Authors:  Hans-Richard Demel; Benedikt Feuerecker; Guido Piontek; Christof Seidl; Birgit Blechert; Anja Pickhard; Markus Essler
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells.

Authors:  Jelena Klawitter; Douglas J Kominsky; Jaimi L Brown; Jost Klawitter; Uwe Christians; Dieter Leibfritz; Junia V Melo; S Gail Eckhardt; Natalie J Serkova
Journal:  Br J Pharmacol       Date:  2009-08-06       Impact factor: 8.739

Review 3.  Targeting cancer metabolism: a therapeutic window opens.

Authors:  Matthew G Vander Heiden
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

4.  Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma.

Authors:  Valentina Di Gialleonardo; Hannah N Aldeborgh; Vesselin Miloushev; Kelly M Folkers; Kristin Granlund; William D Tap; Jason S Lewis; Wolfgang A Weber; Kayvan R Keshari
Journal:  Cancer Res       Date:  2017-04-06       Impact factor: 12.701

5.  ER stress modulates cellular metabolism.

Authors:  Xiaoli Wang; Colins O Eno; Brian J Altman; Yanglong Zhu; Guoping Zhao; Kristen E Olberding; Jeffrey C Rathmell; Chi Li
Journal:  Biochem J       Date:  2011-04-01       Impact factor: 3.857

6.  Anticancer activity and mode of action of titanocene C.

Authors:  Ulrike Olszewski; James Claffey; Megan Hogan; Matthias Tacke; Robert Zeillinger; Patrick J Bednarski; Gerhard Hamilton
Journal:  Invest New Drugs       Date:  2010-02-17       Impact factor: 3.850

7.  Identification of small molecule inhibitors of pyruvate kinase M2.

Authors:  Matthew G Vander Heiden; Heather R Christofk; Eli Schuman; Alexander O Subtelny; Hadar Sharfi; Edward E Harlow; Jun Xian; Lewis C Cantley
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

8.  Mechanisms and methods in glucose metabolism and cell death.

Authors:  Yuxing Zhao; Heather L Wieman; Sarah R Jacobs; Jeffrey C Rathmell
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

9.  Sirt4: the glutamine gatekeeper.

Authors:  Pablo J Fernandez-Marcos; Manuel Serrano
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

10.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.

Authors:  Timothy H Witney; Mikko I Kettunen; Samuel E Day; De-en Hu; Andre A Neves; Ferdia A Gallagher; Sandra M Fulton; Kevin M Brindle
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.